CNTF, STAT3 and new therapies for axonal degeneration: what are they and what can they do?

Saved in:
Bibliographic Details
Published inExpert review of neurotherapeutics Vol. 13; no. 3; pp. 239 - 241
Main Authors Selvaraj, Bhuvaneish Thangaraj, Sendtner, Michael
Format Journal Article
LanguageEnglish
Published England Informa Healthcare 01.03.2013
Taylor & Francis
Expert Reviews Ltd
Subjects
amyotrophic lateral sclerosis
Animal experimentation
Animals
axon
Axons - metabolism
Axons - pathology
Ciliary Neurotrophic Factor - metabolism
Ciliary Neurotrophic Factor - pharmacology
CNTF
cytoskeleton
Degeneration
Gene expression
Humans
motoneuron diseases
Nerve Degeneration - drug therapy
Nerve Degeneration - metabolism
Nerve Degeneration - physiopathology
Nervous system
neurodegeneration
Neurodegenerative Diseases - drug therapy
Neurodegenerative Diseases - metabolism
Neurodegenerative Diseases - physiopathology
neurotrophic factors
Physiological aspects
STAT3
STAT3 Transcription Factor - metabolism
STAT3 Transcription Factor - pharmacology
stathmin
synapses
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Commentary-2
content type line 23
ObjectType-Review-1
ObjectType-Editorial-3
ISSN:1473-7175
1744-8360
DOI:10.1586/ern.13.9